Mapping the Clinical Path With Real World Data
DRG’s Mladen Tomich, Ph.D., Executive Director, Infectious, Niche & Rare Diseases, and Real World Data Expansion, and Keshia Maughn, Director will be presenting at this year’s Pharma Market Research Conference.
Mapping the Clinical Path with Real World Data
Mladen Tomich, Ph.D.
DRG Executive Director, Infectious, Niche & Rare Diseases, and Real World Data Expansion
Keshia Maughn, MPH
DRG Director, Analytics & Operations
February 15, 2018 at 11:25 AM
The growing accessibility of healthcare Real World Data (RWD) has opened up previously unimaginable resources for uncovering pharmaceutical market dynamics. Despite the increasing availability of RWD, its utilization remains extremely challenging. The data is expensive to buy, laborious to process, and requires a great deal of analytical and therapeutic expertise to turn into meaningful, actionable insights. But done right, RWD has the potential to boost brand performance, fine-tune commercial strategy, tease out subtle market nuances, and unlock hidden opportunities. In this session, DRG’s Mladen Tomich, Ph.D., and Keshia Maughn, MPH, will explain how US claims and EHR data can be used to create a detailed roadmap of the treatment journey and provide understanding of the therapeutic landscape for a disease.
Don’t miss our presentation! Access the full schedule here.
To arrange a meeting with one of our experts, please contact us.
We look forward to seeing you in Newark!